Escalon Medical Corp (ESMC)

Healthcare | Medical Devices
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 3,474,192 3,220,556 2,781,346 3,471,771
Cost of Revenue 1,874,287 1,646,575 1,568,188 1,999,915
Gross Profit 1,599,905 1,573,981 1,213,158 1,471,856
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,159,113 1,162,137 1,099,254 1,160,577
Operating Expenses 1,323,868 1,318,077 1,240,113 1,333,553
Operating Income 276,037 255,904 -26,955 138,303
Interest Expense 4,565 4,883 5,262 3,897
Income Before Tax 271,472 246,021 -32,217 134,406
Income Tax Expense 0 0 0 0
Net Income 271,472 246,021 -32,217 134,406
Per Share
EPS 0.02 0.02 0.00 0.02
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Revenue 12,046,148,000 11,981,509 12,180,221 10,703,070 10,471,617
Cost of Revenue 6,535,090,000 6,835,317 6,698,858 6,096,169 6,044,399
Gross Profit 5,511,058,000 5,146,192 5,481,363 4,606,901 4,427,218
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 4,624,711,000 4,562,479 4,184,051 4,085,982 3,570,433
Operating Expenses 5,377,841,000 5,250,668 5,002,820 5,076,964 4,460,915
Operating Income 133,217,000 -104,476 478,543 36,487 -33,697
Interest Expense 22,692,000 20,785 21,717 18,406 21,841
Income Before Tax 105,525,000 -125,261 456,826 18,081 -52,023
Income Tax Expense 0 0 0 18,406 0
Net Income 105,525,000 -125,261 456,826 18,081 -52,023
Per Share
EPS 14.23 -0.02 0.06 0.00 -0.01
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Cash and Cash Equivalents 545,835,000 209,033 889,674 593,869
Short Term Investments 0 0 0 0
Net Receivables 1,667,394,000 2,124,159 1,653,721 1,541,750
Inventory 2,142,263,000 1,613,118 1,587,989 1,603,955
Total Current Assets 4,611,937,000 4,396,828 4,637,467 4,185,782
Property Plant Equipment 288,542,000 248,867 537,711 840,917
Goodwill and Intangibles 0 49,442 69,986 82,750
Total Assets 4,993,059,000 4,757,925 5,307,951 5,172,237
Liabilities
Account Payables 1,387,192,000 1,357,222 1,205,510 1,012,451
Short Term Debt 87,044,000 245,315 369,830 512,818
Total Current Liabilities 2,685,248,000 2,668,939 2,853,059 3,001,998
Long Term Debt 168,015,000 279,404 520,049 692,222
Total Liabilities 3,077,952,000 2,948,343 3,373,108 3,694,220
Shareholders Equity
Retained Earnings -68,439,351,000 -68,544,876 -68,419,615 -68,876,441
Total Shareholders Equity 1,915,107,000 1,809,582 1,934,843 1,478,017
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Assets
Cash and Cash Equivalents 545,835,000 209,033 889,674 593,869 1,650,970
Short Term Investments 0 0 0 0 0
Net Receivables 1,667,394,000 2,124,159 1,653,721 1,541,750 1,081,702
Inventory 2,142,263,000 1,613,118 1,587,989 1,603,955 1,416,727
Total Current Assets 4,611,937,000 4,396,828 4,637,467 4,185,782 4,592,676
Property Plant Equipment 288,542,000 248,867 537,711 840,917 925,001
Goodwill and Intangibles 0 49,442 69,986 82,750 102,400
Total Assets 4,993,059,000 4,757,925 5,307,951 5,172,237 5,682,866
Liabilities
Account Payables 1,387,192,000 1,357,222 1,205,510 1,012,451 1,102,125
Short Term Debt 87,044,000 245,315 369,830 512,818 986,889
Total Current Liabilities 2,685,248,000 2,668,939 2,853,059 3,001,998 3,396,763
Long Term Debt 168,015,000 279,404 520,049 692,222 785,307
Total Liabilities 3,077,952,000 2,948,343 3,373,108 3,694,220 4,222,930
Shareholders Equity
Retained Earnings -68,439,351,000 -68,544,876 -68,419,615 -68,876,441 -68,894,522
Total Shareholders Equity 1,915,107,000 1,809,582 1,934,843 1,478,017 1,459,936
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income 105,525,000 -125,261 456,826 18,081
Depreciation & Amortization 37,819,000 46,015 45,202 48,432
Stock Based Compensation 0 0 0 0
Change in Working Capital 0 -810,110 -644,439 -1,045,119
Operating Cash Flow 380,725,000 -602,771 325,146 -1,049,925
Investing Activities
Capital Expenditure 0 -40,285 -13,842 0
Investments 0 -40,285 -13,842 0
Investing Cash Flow -3,880,000 -40,285 -13,842 0
Financing Activities
Debt Repayment 0 -37,456 -15,371 -6,931
Common Stock Issued/Repurchased 0 0 0 0
Dividends Paid 0 0 0 0
Financing Cash Flow -39,915,000 -37,456 -15,371 -6,931
Summary
Free Cash Flow 380,725,000 -643,056 311,304 -1,049,925
Net Change in Cash 336,930,000 -680,512 295,933 -1,056,856
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Activities
Net Income 105,525,000 -125,261 456,826 18,081 -52,023
Depreciation & Amortization 37,819,000 46,015 45,202 48,432 44,812
Stock Based Compensation 0 0 0 0 0
Change in Working Capital 0 -810,110 -644,439 -1,045,119 561,301
Operating Cash Flow 380,725,000 -602,771 325,146 -1,049,925 838,705
Investing Activities
Capital Expenditure 0 -40,285 -13,842 0 -9,390
Investments 0 -40,285 -13,842 0 -9,390
Investing Cash Flow -3,880,000 -40,285 -13,842 0 -9,390
Financing Activities
Debt Repayment 0 -37,456 -15,371 -6,931 -3,664
Common Stock Issued/Repurchased 0 0 0 0 0
Dividends Paid 0 0 0 0 0
Financing Cash Flow -39,915,000 -37,456 -15,371 -6,931 -3,664
Summary
Free Cash Flow 380,725,000 -643,056 311,304 -1,049,925 829,315
Net Change in Cash 336,930,000 -680,512 295,933 -1,056,856 825,651